Roche plays host to employees’ children
Basel, 13 November 2013
Young people offered a chance to explore the world of science on National Future Day
On 14 November Roche is playing host to boys and girls between the ages of 10 and 16. For one day, the youngsters will leave their classrooms to explore their parents’ working world. They will discover more about the exciting world of science while also experiencing the wide array of jobs and career opportunities available at Roche.
“On National Future Day we want to give our young visitors a chance to experience some of the fascinating science of drug development and diagnostics,” said Matthias M. Baltisberger, Roche Basel Site Head. “We also want to give them fresh ideas for their own career choices and hope that we can spark an interest in science in some of them.”
At a theatre-style event entitled On Molecules and Medicines, children can learn about the complex issues that scientists have to resolve when they develop a medicine, while the Roche World of Experience exhibition focuses on chemistry, biology, pharmaceutical formulation and training. There will be interesting insights into how medicines are discovered and developed, and the youngsters will have a chance to express their own ideas on the excitement of science in a big painting competition.
How Roche fosters new talent
Fostering talent has high priority at Roche. The company provides top-class training to young people in around 400 apprenticeships at its sites in Switzerland. In addition, about 250 students complete an internship each year, and over 1500 schoolchildren and students benefit from guided tours and educational presentations providing insights into the company’s activities. Through its support for foundations such as Simply Science, Swiss Youth in Science (SJf) and SJf’s Swiss Talent Forum, Roche enables young people to engage creatively with new and unifying elements in art, science and technology.
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, infectious diseases, inflammation, metabolism and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2012 Roche had over 82,000 employees worldwide and invested over 8 billion Swiss francs in R&D. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.
All trademarks used or mentioned in this release are protected by law.